Together, these findings highlight a novel layer of translational regulation in diabetic cardiomyopathy, wherein miRNAs and AGO2 modulate mitochondrial protein synthesis in a target-specific manner. The gene discussed is AGO2; the disease is diabetic cardiomyopathy.